Non-Current Assets
Long-term marketable securities
Elevance Health Long-term marketable securities decreased by 0.6% to $1.11B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.1%, from $1.06B to $1.11B. Over 5 years (FY 2020 to FY 2025), Long-term marketable securities shows an upward trend with a 14.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026Apr 22, 2026
How to read this metric
Growth in this balance reflects the company's strategy to invest excess capital into long-term income-generating assets.
Detailed definition
These are long-term debt securities held by the company that are classified as available for sale. Unlike current assets...
Peer comparison
Health insurers maintain large long-term investment portfolios to ensure they can meet long-term insurance obligations.
Metric ID:
non_current_assets_available_for_sale_securities_debt_se_908f76Historical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $581M | $625M | $632M | $596M | $603M | $622M | $752M | $783M | $775M | $816M | $876M | $880M | $849M | $893M | $1.04B | $1.06B | $1.09B | $1.11B | $1.12B | $1.11B |
| QoQ Change | — | +7.6% | +1.1% | -5.7% | +1.2% | +3.2% | +20.9% | +4.1% | -1.0% | +5.3% | +7.4% | +0.5% | -3.5% | +5.2% | +15.9% | +2.4% | +2.5% | +2.2% | +0.9% | -0.6% |
| YoY Change | — | — | — | — | +3.8% | -0.5% | +19.0% | +31.4% | +28.5% | +31.2% | +16.5% | +12.4% | +9.5% | +9.4% | +18.2% | +20.5% | +28.0% | +24.4% | +8.3% | +5.1% |
Range$581M – $1.12B
CAGR+14.7%
Avg YoY Growth+16.6%
Median YoY Growth+17.3%
Long-term marketable securities at Other Companies
Frequently Asked Questions
- What is Elevance Health's long-term marketable securities?
- Elevance Health (ELV) reported long-term marketable securities of $1.11B in Q1 2026.
- How has Elevance Health's long-term marketable securities changed year-over-year?
- Elevance Health's long-term marketable securities increased by 5.1% year-over-year, from $1.06B to $1.11B.
- What is the long-term trend for Elevance Health's long-term marketable securities?
- Over 5 years (2020 to 2025), Elevance Health's long-term marketable securities has grown at a 14.8% compound annual growth rate (CAGR), from $562M to $1.12B.
- What does long-term marketable securities mean?
- Long-term debt investments that the company holds for more than one year.